Open AccessNeurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
Author(s) -
Benitez Hidalgo Olga,
Martinez Garcia M. Fernanda,
Bescos Cabestre Agustin,
Juarez Gimenez Juan Carlos,
Gironella Mesa Mercedes,
Bosch Albareda Francesc
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5848
Subject(s) - medicine , neurosurgery , perioperative , factor ix , surgery , general surgery
Abstract Extended half‐life FIX (EHL‐FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63‐year‐old patient with severe hemophilia B (sHB) treated with FIX‐Fc fusion protein (rFIXFc) who underwent neurosurgery.